28 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
# Senior Executive Cash Incentive Bonus Plan S-1 333–248719 09/10/2020 10.4 10.5# Form of Director Indemnification Agreement S-1 333–248719 09/10/2020 … , or RSAs, restricted stock units, or RSUs, performance awards and stock bonus awards to the Company’s officers, employees, directors and other key
8-K
CCCC
C4 Therapeutics Inc
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm
and will be eligible to receive an annual performance bonus of up to 40% of her base salary. In connection with her appointment, Ms. Adams will also receive … to this new role, he will receive an annual base salary of $315,000 and be eligible to receive an annual performance bonus of up to 30% of his base salary.
Mr
8-K
CCCC
C4 Therapeutics Inc
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
, a sign-on bonus of $200,000 and an opportunity to earn a performance bonus of up to 40% of his base salary per year. Dr. Reyno’s performance bonus, if any
ARS
s83cypfu0ojhycv 0ct
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
j1dea0
18 Apr 23
Preliminary proxy
7:59am
S-3ASR
EX-1.2
5ida 0n9w
10 Nov 21
Automatic shelf registration
5:19pm
424B4
novxbpq
21 Jun 21
Prospectus supplement with pricing info
8:08am
8-K
6epafyl
20 May 21
C4 Therapeutics Appoints Lauren White as Chief Financial Officer
4:22pm
DRS
t74cm
19 May 21
Draft registration statement
12:00am
DEF 14A
jdswu hpa9x89ym
26 Apr 21
Definitive proxy
4:22pm
10-K
7tfmveu3
11 Mar 21
Annual report
4:19pm
10-Q
naahaonzymkdlzyyw
12 Nov 20
Quarterly report
4:28pm
424B4
m73nk
2 Oct 20
Prospectus supplement with pricing info
5:10pm